Detalles de la búsqueda
1.
Identification and Characterization of Circulating Tumor Cells in Men Who have Undergone Prostatectomy for Clinically Localized, High Risk Prostate Cancer.
J Urol
; 202(4): 732-741, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-31216253
2.
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients.
BMC Cancer
; 16(1): 744, 2016 Sep 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-27658492
3.
A multidisciplinary team-based approach with lifestyle modification and symptom management to address the impact of androgen deprivation therapy in prostate cancer: A randomized phase II study.
Urol Oncol
; 39(10): 730.e9-730.e15, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34304981
4.
A multicenter phase I study of cabazitaxel, mitoxantrone, and prednisone for chemotherapy-naïve patients with metastatic castration-resistant prostate cancer: A department of defense prostate cancer clinical trials consortium study.
Urol Oncol
; 35(4): 149.e7-149.e13, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28161323
5.
An improved CTC isolation scheme for pairing with downstream genomics: Demonstrating clinical utility in metastatic prostate, lung and pancreatic cancer.
Cancer Lett
; 380(1): 144-52, 2016 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-27343980
Resultados
1 -
5
de 5
1
Próxima >
>>